Inhibrx Biosciences, Inc. revenue growth has been varied year-over-year.

What is INBX's revenue growth rate?

Historical revenue data is available for Inhibrx Biosciences, Inc. to analyze growth trends.

How fast is INBX earnings growing?

Earnings growth data is available for Inhibrx Biosciences, Inc. analysis.

What is INBX's profit margin?

Profit margin data is available for Inhibrx Biosciences, Inc..

INBX Revenue & Earnings Growth Analysis 2026 - Is Inhibrx Biosciences, Inc. Growing?

Growth Summary

Inhibrx Biosciences, Inc. (INBX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.

Over the past 1 years, Inhibrx Biosciences, Inc. has achieved a revenue compound annual growth rate (CAGR) of -88.9%, while earnings have grown at -799.2% CAGR.

Latest Revenue

$200.00K

Net Income

$1.69B

5-Year Revenue CAGR

-88.9%

1 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Inhibrx Biosciences, Inc.

The chart above illustrates Inhibrx Biosciences, Inc.'s revenue trajectory over the past 1 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Inhibrx Biosciences, Inc.'s business.

Profit Margin Trends

How efficiently Inhibrx Biosciences, Inc. converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Inhibrx Biosciences, Inc. retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$-5.46

Current: $114.01

EPS Estimate 2027

$-2.79

-48.9% expected growth

Price Target

$12.00

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Inhibrx Biosciences, Inc. to continue growing earnings in the coming year.

Growth Analysis Conclusion

Based on our comprehensive analysis, Inhibrx Biosciences, Inc. (INBX) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, -88.9% CAGR over 1 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Inhibrx Biosciences, Inc.'s historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.